Emory University’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-77,180
| Closed | -$895K | – | 11 |
|
|
2019
Q3 | $895K | Sell |
77,180
-46,420
| -38% | -$538K | 1.76% | 13 |
|
|
2019
Q2 | $2.48M | Buy |
123,600
+12,973
| +12% | +$261K | 1.75% | 13 |
|
|
2019
Q1 | $2.5M | Buy |
110,627
+17,687
| +19% | +$400K | 1.76% | 13 |
|
|
2018
Q4 | $2.1M | Sell |
92,940
-4,570
| -5% | -$103K | 1.66% | 18 |
|
|
2018
Q3 | $2.8M | Buy |
+97,510
| New | +$2.8M | 1.83% | 15 |
|
|
2018
Q2 | – | Sell |
-115,136
| Closed | -$2.57M | – | 49 |
|
|
2018
Q1 | $2.57M | Buy |
115,136
+30,251
| +36% | +$676K | 1.84% | 14 |
|
|
2017
Q4 | $1.79M | Buy |
84,885
+10,968
| +15% | +$231K | 1.54% | 32 |
|
|
2017
Q3 | $1.84M | Sell |
73,917
-17,191
| -19% | -$428K | 1.46% | 18 |
|
|
2017
Q2 | $1.77M | Buy |
+91,108
| New | +$1.77M | 1.56% | 9 |
|